ArticleFrontiers in cardiovascular medicine2025
Impact of chest computed tomography-determined low skeletal muscle mass on the survival of patients with acute heart failure.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Total Pectoral Muscle Area and Prognostic Nutritional Index Provide Complementary Prognostic Information for Patients Hospitalized with HFmrEF/HFrEF.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Computed tomography (CT)-determined low skeletal muscle mass (SMM) has been reported to be associated with poor clinical outcomes in various diseases; however, limited information is available regarding patients with heart failure (HF). Our research aimed to investigate the prognostic significance of low SMM assessed by chest CT scans in hospitalized patients with acute heart failure (AHF). Methods: Skeletal muscle index (SMI) was assessed using chest CT scans at the twelfth thoracic vertebra (T12) level, and sex-specific optimal cutoff values for T12 SMI were determined using the X-tile program based on all-cause mortality. The outcomes of this study were all-cause death and cardiovascular death. Cox proportional hazards models were employed to identify the risk factors for mortality. Results: This study enrolled 305 inpatients with AHF (62.3% males). According to the optimum cutoff value (31.9 cm Conclusions: Chest CT-determined low SMM has the potential to serve as a valuable imaging prognostic indicator for predicting adverse outcomes in AHF patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.